AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026
Key Highlights
- ➤Amgen (AMGN) will present oncology portfolio data at ESMO 2026.
- ➤Investor webcast scheduled October 24, 2026, at 11:30 a.m. PT.
- ➤Amgen executives Murdo Gordon and Jean-Charles Soria will discuss selected data.
- ➤Webcast replay will remain available for at least 30 days.
Expert Statements
Murdo Gordon, Executive vice president of Global Markets and Policy at Amgen
“Amgen's oncology portfolio and selected data being presented at ESMO 2026”
Jean-Charles Soria, Senior vice president of oncology within Global Development at Amgen
“Amgen's oncology portfolio and selected data being presented at ESMO 2026”
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026 PR Newswire
THOUSAND OAKS, Calif., Oct. 20, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the European Society of Medical Oncology Congress (ESMO) 2026 on Saturday, October 24, 2026 at 11:30 a.m. PT. Murdo Gordon, executive vice president of Global Markets and Policy at Amgen, and Jean-Charles Soria, senior vice president of oncology within Global Development at Amgen, as well as other members of Amgen's management team, will discuss Amgen's oncology portfolio and selected data being presented at ESMO 2026. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
Get started
Create a free account to read the full story.